Plasma levels of matrix metalloproteinase-9: A possible diagnostic marker of successful endovascular aneurysm repair

European Journal of Vascular and Endovascular Surgery

Volumn 43, Issue 2, 2012, Pages 171-172

  Hellenthal, F A M V I ^a,b   Ten Bosch, J A ^c   Pulinx, B ^a   Wodzig, W K W H ^a   De Haan, M W ^a,b   Prins, M H ^a   Welten, R J T J ^c   Teijink, J A W ^d   Schurink, G W H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

Author keywords

Abdominal aortic aneurysm; Diagnosis; Endoleak; MMP 9

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA ANEURYSM; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOLEAK; ENDOVASCULAR ANEURYSM REPAIR; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; ENDOLEAK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855565965     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.10.014     Document Type: Article

References (5)

1. Drury D, Michaels JA, Jones L, Ayiku L. Systematic review of recent evidence for the safety and efficacy of elective endovascular repair in the management of infrarenal abdominal aortic aneurysm. Br J Surg 2005;92(8):937-46. (Pubitemid 41160782)
2. Prinssen M, Wixon CL, Buskens E, Blankensteijn JD. Surveillance after endovascular aneurysm repair: diagnostics, complications, and associated costs. Ann Vasc Surg 2004;18(4):421-7. (Pubitemid 39014603)
3. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol 2009;6(7):464-74.
4. Sangiorgi G, D'Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001;104(12 suppl. 1):I288-95. (Pubitemid 32884818)
5. Lorelli DR, Jean-Claude JM, Fox CJ, Clyne J, Cambria RA, Seabrook GR, et al. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg 2002;35(5):916-22. (Pubitemid 44718559)